Dr. Bander Awarded CNS James Rutka Pediatric Brain Tumor Award

Seventh-year resident Evan Bander, MD, was named winner of the prestigious James Rutka Pediatric Brain Tumor Award by the AANS/CNS Section on Tumors for his abstract “A Positive Impact on Patterns of Relapse in Diffuse Intrinsic Pontine Glioma after Convection-Enhanced Delivery of Omburtamab.” The winning abstract, based on a study Dr. Bander conducted with Dr. Mark Souweidane, evaluates the outcomes of DIPG patients treated with convection-enhanced delivery (CED) in Dr. Souweidane’s clinical trial.

The study looked at 63 children with DIPG treated between 2010 and 2022, all of whom received conventional external beam radiation (EBRT); 31 received CED of radiolabeled 124-Iodine-Omburtamab following radiation.

Dr. Bander in the OR with Dr. Souweidane

Dr. Bander in the OR with Dr. Souweidane

Although the study showed only a trend in improved overall survival, CED treatment was associated with a statistically significant decrease in local progression rates relative to the control group. That prompts consideration for modifying the design of future trials with serial treatments for a wider treatment field or with craniospinal irradiation.

Dr. Bander delivered his abstract at the 2022 CNS annual meeting in San Francisco. 



Neurological Surgery 525 E. 68th St., Starr 651, Box 99 New York, NY 10065